/ Published in 2015, Publication

Acyclovir Prophylaxis Reduces the Incidence of Herpes Zoster Among HIV-Infected Individuals

Acyclovir Prophylaxis Reduces the Incidence of Herpes Zoster Among HIV-Infected Individuals: Results of a Randomized Clinical Trial.

Barnabas RV, Baeten JM, Lingappa JR, Thomas KK, Hughes JP, Mugo NR, Delany-Moretlwe S, Gray G, Rees H, Mujugira A, Ronald A, Stevens W, Kapiga S, Wald A, Celum C; Partners in Prevention HSV/HIV Transmission Study Team.

J Infect Dis. 2015. 213:551-5.

PMID:26142452

PMCID:PMC4721901

DOI:10.1093/infdis/jiv318

Related citation

What you can read next

Effects of Schistosoma haematobium infection and treatment on the systemic and mucosal immune phenotype, gene expression and microbiome: A systematic review.
Risk factors for Herpes simplex virus type 2 and HIV among women at high risk in north-western Tanzania: preparing for an HSV-2 intervention trial. Journal of Acquired Immune Deficiency Syndromes 2007; 46: 631-642.
Microbicides Development Programme (MDP). How informed is consent in vulnerable populations? Experience using a continuous consent process during the MDP301 vaginal microbicide trial in Mwanza, Tanzania.